Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2009 Jul 22;47:e6330. doi: 10.1371/journal.pone.0006330.
Show Gene links
Show Anatomy links
KCNE1 and KCNE3 beta-subunits regulate membrane surface expression of Kv12.2 K(+) channels in vitro and form a tripartite complex in vivo.
Clancy SM
,
Chen B
,
Bertaso F
,
Mamet J
,
Jegla T
.
???displayArticle.abstract???
Voltage-gated potassium channels that activate near the neuronal resting membrane potential are important regulators of excitation in the nervous system, but their functional diversity is still not well understood. For instance, Kv12.2 (ELK2, KCNH3) channels are highly expressed in the cerebral cortex and hippocampus, and although they are most likely to contribute to resting potassium conductance, surprisingly little is known about their function or regulation. Here we demonstrate that the auxiliary MinK (KCNE1) and MiRP2 (KCNE3) proteins are important regulators of Kv12.2 channel function. Reduction of endogenous KCNE1 or KCNE3 expression by siRNA silencing, significantly increased macroscopic Kv12.2 currents in Xenopus oocytes by around 4-fold. Interestingly, an almost 9-fold increase in Kv12.2 currents was observed with the dual injection of KCNE1 and KCNE3 siRNA, suggesting an additive effect. Consistent with these findings, over-expression of KCNE1 and/or KCNE3 suppressed Kv12.2 currents. Membrane surface biotinylation assays showed that surface expression of Kv12.2 was significantly increased by KCNE1 and KCNE3 siRNA, whereas total protein expression of Kv12.2 was not affected. KCNE1 and KCNE3 siRNA shifted the voltages for half-maximal activation to more hyperpolarized voltages, indicating that KCNE1 and KCNE3 may also inhibit activation gating of Kv12.2. Native co-immunoprecipitation assays from mouse brain membranes imply that KCNE1 and KCNE3 interact with Kv12.2 simultaneously in vivo, suggesting the existence of novel KCNE1-KCNE3-Kv12.2 channel tripartite complexes. Together these data indicate that KCNE1 and KCNE3 interact directly with Kv12.2 channels to regulate channel membrane trafficking.
???displayArticle.pubmedLink???
19623261
???displayArticle.pmcLink???PMC2710002 ???displayArticle.link???PLoS One ???displayArticle.grants???[+]
Figure 1. Knockdown of endogenous KCNE expression in Xenopus oocytes with siRNA.(AâE) RT-PCR of xKCNE1, xKCNE3 and xKCNE5.1 mRNA isolated from Xenopus oocytes injected with dH2O (â) or the indicated siRNA (+). RT-PCR for β-actin is shown as a control for normalization of band intensity. (AâC) siRNAs designed against xKCNE1, xKCNE3 and xKCNE5.1 all significantly knock down mRNA expression level of their respective target genes. (DâE) In contrast, siRNA targeted to xKCNE1 and xKCNE3 do not affect mRNA expression levels of other KCNE genes. (F) Optical density of cDNA bands relative to β-actin was quantified using NIH ImageJ. xKCNE1, xKCNE3 and xKCNE5.1 siRNA bands indicted a â¼10-fold, â¼4-fold, and â¼4fold reduction in expression of each respective gene; control injections did not show a significant reduction. Each experiment was performed 3 times; values show Mean±SEM, ** p<0.01.
Figure 2. KCNE1 and KCNE3 inhibit Kv12.2 currents in Xenopus oocytes.(AâE) Current traces recorded from oocytes injected with (A) Kv12.2 cRNA only, or co-injected (B) KCNE1, (C) KCNE3, (D) KCNE1 and KCNE3, or (E) KCNE5.1 siRNAs. Currents were recorded in response to 2 s voltage steps from â100 to +80 mV, in 20 mV increments from a holding potential of â100 mV; tail currents were recorded at â40 mV (protocol in inset). (F) Peak current-voltage relationships from oocytes injected with Kv12.2 cRNA only (âª), or Kv12.2 cRNA plus either KCNE1 (â¢), KCNE3 (â´), KCNE1 and KCNE3 (â¾), or KCNE5.1 (â¦) siRNAs. KCNE1 and KCNE3 siRNAs significantly increase Kv12.2 currents and have an additive effect in combination. (Mean±SEM, nâ=â12â16, ** p<0.01). (G) Normalized conductance voltage (GV) curves measured from isochronal tail currents for oocytes injected with Kv12.2 cRNA only (âª), and either KCNE1 (â¢), KCNE3 (â´), or KCNE1+KCNE3 (â¾) siRNA. Lines show Boltzmann fits; parameters are given in the Results. Only dual injection of xKCNE1 and xKCNE3 siRNAs caused a significant shift in V50. Data are given as Mean±SEM, nâ=â12â16, (** p<0.01). (H) Peak current-voltage relationships from oocytes injected with Kv12.2 cRNA (âª), or Kv12.2 cRNA+mKCNE1 (â¢), mKCNE3 (â´), mKCNE1 and mKCNE3 (â¾) cRNA (protocol as in A, Mean±SEM, nâ=â8, * p<0.05, ** p<0.01). Co-injection of Kv12.2 with mKCNE1 and/or mKCNE3 cRNA significantly reduced Kv12.2 currents. (I) GV curves from isochronal tail currents recorded from oocytes injected with Kv12.2 cRNA (âª), or Kv12.2 and either mKCNE1 (â¢), mKCNE3 (â´), and mKCNE1 and mKCNE3 (â¾) cRNA. Boltzmann fits (lines) revealed that the voltage-dependence of Kv12.2 activation was not significantly affected by overexpression of KCNE1 and KCNE3. V50 values are given in the Results (nâ=â8).
Figure 3. Characterization of the Kv12.2 channel antibody.(A) Alignment of a 100 amino acid section, 702â801 of the cytoplasmic C-terminus of mouse Kv12.2 used to generate a Kv12.2-specific polyclonal antibody in rabbit to Kv12.1. The homologous region of Kv12.3 (not shown), is most similar to Kv12.1. Amino acid identities are shaded and numbers indicate amino acid position in Kv12.2. The cartoon depicts a Kv12.2 subunit with 6 transmembrane domains (S1âS6), a Per-Arnt-Sim (PAS) motif and a putative cyclic nucleotide binding motif (cNBD). Gray scale coding indicates the level of amino acid identity shared between Kv12.2 and other Kv12 channels in each region of the channel. (B) Top panel, Western blot analysis demonstrates that the Kv12.2 antibody (anti-Kv12.2) recognizes a single band of â¼120 KD (the predicted size of a Kv12.2 channel monomer) from mouse brain and HEK-293 cells transiently transfected with mKv12.2 channel cDNA (HEK-293+Kv12.2). Anti-Kv12.2 did not recognize specific bands in non-transfected HEK-293 cell lysates (HEK-293), in HEK-293 cells transfected with the closely related Kv12.1 channel (HEK-293+Kv12.1), or when excess antigenic control peptide (CP) was present to block immunodetection (HEK-293+Kv12.2+CP). Bottom panel, anti-β-actin demonstrates equal protein loading for each condition. These experiments were repeated 4 times yielding similar results.
Figure 4. KCNE1 and KCNE3 reduce membrane surface expression of Kv12.2 channels.(A) Blots of the biotinylated plasma membrane fraction of proteins from Xenopus oocytes injected with Kv12.2 cRNA alone or in combination with KCNE1 and/or KCNE3 siRNA subjected to membrane surface biotinylation. Top panel, Detection of Kv12.2 channel protein with anti-Kv12.2. Xenopus oocytes injected with Kv12.2 cRNA showed just detectable membrane surface expression; whereas the co-injection of KCNE1 and/or KCNE3 siRNA dramatically increased Kv12.2 channel plasma membrane expression. Kv12.2 was not detected in oocytes injected with dH2O (negative control), and was robustly detected in mouse whole brain lysate (positive control). An endoplasmic reticulum (ER) marker (calnexin, middle panel), and a cell membrane marker (β1-integrin, bottom panel), were used as a negative and positive controls, respectively, to show specific isolation of the plasma membrane protein fraction and to confirm equal protein loading. (B) The optical density of each Kv12.2 protein band was quantified using NIH ImageJ and normalized to density of β1-integrin for comparison; both xKCNE1 or xKCNE3 siRNA increased Kv12.2 channel membrane expression>3-fold (Mean±SEM, nâ=â4, ** p<0.01). Furthermore, the combination KCNE1 and KCNE3 siRNA increased surface Kv12.2 expression â¼20% further than either siRNA alone (nâ=â4, * p<0.05). (C) Blots showing total protein expression from Xenopus oocytes injected as in A. Top panel, Kv12.2 channel total expression was not detected in dH2O-injected oocytes, and did not increase when Kv12.2 was injected with siRNA for KCNE1 and/or KCNE3. Bottom panel, β-actin was used to confirm equal protein loading for each condition assessed. (D) The optical density of each Kv12.2 protein band was quantified using NIH ImageJ and normalized to β-actin; xKCNE1, xKCNE3 or KCNE1 and KCNE3 siRNA did not significantly affect total Kv12.2 channel expression (Mean±SEM, nâ=â4).
Figure 5. Kv12.2 channels simultaneously associate with KCNE1 and KCNE3 β-subunits in vivo.(A) Mouse brain lysates (MB) were immunoprecipitated (IP) with anti-KCNE1, anti-KCNE3, anti-Kv12.2, or anti-Kir2.1 and were then subjected to SDS-PAGE and Western Blot analysis. Whole mouse brain lysate (MB) and proteins precipitated with unconjugated beads (AG only) are shown as positive and negative controls, respectively. Proteins used for IP are indicated at the top, proteins detected in Western blot (IB) are indicated at the left. Top panel, IB with anti-Kv12.2 indicates that both KCNE1 and KCNE3 interact in vivo with Kv12.2 channels. Middle panel, IB was stripped and re-probed with anti-KCNE1. KCNE1 immunoprecipitates with Kv12.2 but not KCNE3. Bottom panel, IB was then re-stripped and re-probed with anti-KCNE3. KCNE3 immunoprecipitates with Kv12.2 but does not interact with KCNE1. Controls show little or no IP of Kv12.2, KCNE1 or KCNE3 with anti-Kir2.1 or unconjugated beads. (BâD) Two-step co-immunoprecipitation assays run under native protein conditions. The Kv12.2 channel complex labeled under native conditions was â¼500 Kd, consistent with a channel tetramer. (B) Kv12.2 channels were immunoprecipitated first with anti-KCNE1 or anti-KCNE3 in these native protein conditions. Specificity was assessed using the anti-Kir2.1 antibody and unconjugated beads as negative controls. Proteins immunoprecipitated in this first IP were subjected to a second IP using anti-Kv12.2. (C) Anti-KCNE1 detected the Kv12.2 tetramer complex after the second IP regardless of whether anti-KCNE1 or anti-KCNE3 was used for the first IP. (D) Similarly, anti-KCNE3 detected the Kv12.2 complex after the second IP with anti-Kv12.2 even if anti-KCNE1 was used for the first IP. These results can be explained if KCNE1 and KCNE3 simultaneously interact with individual Kv12.2 channels. Denatured mouse brain lysate was loaded into the first lane, to confirm the established size of the respective KCNE β-subunit. Note that some KCNE1 has dissociated from the channel complex in the KCNE1 lane of (C).
Abbott,
MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia.
1999, Pubmed,
Xenbase
Abbott,
MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia.
1999,
Pubmed
,
Xenbase
Abbott,
MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis.
2001,
Pubmed
,
Xenbase
Anantharam,
RNA interference reveals that endogenous Xenopus MinK-related peptides govern mammalian K+ channel function in oocyte expression studies.
2003,
Pubmed
,
Xenbase
Barhanin,
K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current.
1996,
Pubmed
,
Xenbase
Brenner,
BK channel beta4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures.
2005,
Pubmed
Chandrasekhar,
KCNE1 subunits require co-assembly with K+ channels for efficient trafficking and cell surface expression.
2006,
Pubmed
Chen,
Charybdotoxin binding in the I(Ks) pore demonstrates two MinK subunits in each channel complex.
2003,
Pubmed
,
Xenbase
Decher,
KCNE2 modulates current amplitudes and activation kinetics of HCN4: influence of KCNE family members on HCN4 currents.
2003,
Pubmed
,
Xenbase
Engeland,
Cloning and functional expression of rat ether-à-go-go-like K+ channel genes.
1998,
Pubmed
Grunnet,
KCNE4 is an inhibitory subunit to the KCNQ1 channel.
2002,
Pubmed
,
Xenbase
Grunnet,
KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels.
2003,
Pubmed
,
Xenbase
Jegla,
Evolution of the human ion channel set.
2009,
Pubmed
Jegla,
A novel subunit for shal K+ channels radically alters activation and inactivation.
1997,
Pubmed
Lundby,
KCNE3 is an inhibitory subunit of the Kv4.3 potassium channel.
2006,
Pubmed
,
Xenbase
Lundquist,
Expression of multiple KCNE genes in human heart may enable variable modulation of I(Ks).
2005,
Pubmed
Manderfield,
KCNE4 can co-associate with the I(Ks) (KCNQ1-KCNE1) channel complex.
2008,
Pubmed
McCrossan,
The MinK-related peptides.
2004,
Pubmed
,
Xenbase
McCrossan,
Regulation of the Kv2.1 potassium channel by MinK and MiRP1.
2009,
Pubmed
McCrossan,
MinK-related peptide 2 modulates Kv2.1 and Kv3.1 potassium channels in mammalian brain.
2003,
Pubmed
McDonald,
A minK-HERG complex regulates the cardiac potassium current I(Kr).
1997,
Pubmed
,
Xenbase
Melman,
KCNE1 binds to the KCNQ1 pore to regulate potassium channel activity.
2004,
Pubmed
Miyake,
New ether-à-go-go K(+) channel family members localized in human telencephalon.
1999,
Pubmed
Miyashita,
Localization and developmental changes of the expression of two inward rectifying K(+)-channel proteins in the rat brain.
1997,
Pubmed
Morin,
Counting membrane-embedded KCNE beta-subunits in functioning K+ channel complexes.
2008,
Pubmed
,
Xenbase
Nicolas,
KCNQ1/KCNE1 potassium channels in mammalian vestibular dark cells.
2001,
Pubmed
Piccini,
KCNE1-like gene is deleted in AMME contiguous gene syndrome: identification and characterization of the human and mouse homologs.
1999,
Pubmed
Saganich,
Differential expression of genes encoding subthreshold-operating voltage-gated K+ channels in brain.
2001,
Pubmed
Sanguinetti,
Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.
1996,
Pubmed
,
Xenbase
Schroeder,
A constitutively open potassium channel formed by KCNQ1 and KCNE3.
2000,
Pubmed
,
Xenbase
Sesti,
A common polymorphism associated with antibiotic-induced cardiac arrhythmia.
2000,
Pubmed
Shi,
Cloning of a mammalian elk potassium channel gene and EAG mRNA distribution in rat sympathetic ganglia.
1998,
Pubmed
,
Xenbase
Splawski,
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.
2000,
Pubmed
Strutz-Seebohm,
Functional coassembly of KCNQ4 with KCNE-beta- subunits in Xenopus oocytes.
2006,
Pubmed
,
Xenbase
Takumi,
Cloning of a membrane protein that induces a slow voltage-gated potassium current.
1988,
Pubmed
,
Xenbase
Trudeau,
Functional analysis of a mouse brain Elk-type K+ channel.
1999,
Pubmed
,
Xenbase
Tyson,
Mutational spectrum in the cardioauditory syndrome of Jervell and Lange-Nielsen.
2000,
Pubmed
Um,
Differential association between HERG and KCNE1 or KCNE2.
2007,
Pubmed
Warth,
The multifaceted phenotype of the knockout mouse for the KCNE1 potassium channel gene.
2002,
Pubmed
Xu,
MinK-dependent internalization of the IKs potassium channel.
2009,
Pubmed
Yu,
MinK-related peptide 1: A beta subunit for the HCN ion channel subunit family enhances expression and speeds activation.
2001,
Pubmed
,
Xenbase
Zhang,
Divalent cations slow activation of EAG family K+ channels through direct binding to S4.
2009,
Pubmed
,
Xenbase
Zhang,
minK-related peptide 1 associates with Kv4.2 and modulates its gating function: potential role as beta subunit of cardiac transient outward channel?
2001,
Pubmed
,
Xenbase
Zou,
Distribution and functional properties of human KCNH8 (Elk1) potassium channels.
2003,
Pubmed
,
Xenbase